Rimegepant 75 mg demonstrates efficacy for acute vestibular migraine treatment, improving vertigo, unsteadiness, nausea, and headache symptoms in patients meeting VM diagnostic criteria.
All 5 VM symptoms improvedRimegepant reduced vertigo, unsteadiness, nausea, sensory sensitivity, and headache
What the researchers found
Rimegepant 75 mg effectively treated acute vestibular migraine symptoms including vertigo, unsteadiness, nausea/vomiting, photo/phonophobia, and headache.
Why it matters
Vestibular migraine is the most common cause of episodic vertigo, affecting millions, yet has no FDA-approved treatment. Demonstrating rimegepant efficacy could change clinical practice.
How the study worked
Clinical study of rimegepant 75 mg for acute VM attacks; patients meeting VM/probable VM criteria; 5 symptom severity ratings (0-3 scale) at multiple time points.
What this study cannot tell us
Likely open-label without placebo control; sample size may be small; short-term acute treatment only; VM diagnostic criteria overlap makes patient selection challenging.
How to read the evidence
Clinical study — provides important efficacy data but may lack placebo control for definitive evidence.
When this study was published
Published in 2026, pioneering CGRP antagonist therapy specifically for vestibular migraine.
The bigger picture
This extends CGRP antagonist therapy from traditional migraine headache to vestibular migraine, suggesting CGRP plays a central role in both the pain and vestibular components of migraine.
Questions still open
- Should rimegepant be studied in a larger placebo-controlled trial specifically for vestibular migraine?
- Does preventive rimegepant use reduce vestibular migraine attack frequency?
Common questions
What is vestibular migraine?
Can rimegepant help with dizziness, not just headache?
Read the original research
The efficacy of rimegepant for the acute treatment of vestibular migraine.
Scientific reports
Citation
Chu, Heling; Pan, Jingwei; Huang, Chuyi. (2026). The efficacy of rimegepant for the acute treatment of vestibular migraine.. Scientific reports. https://doi.org/10.1038/s41598-026-39902-9